DPP4 and breast cancer: First, we confirmed that DPP-4 inhibition by KR activated S6 Kinase (S6K), an mTORC1 downstream effector, and that rapamycin significantly suppressed the induction of phosphorylated S6K by KR in 4T1 murine mammary tumor cells (Supplementary Figure S2).